Portfolio news 0

Oxford Quantum Circuits Limited

OQC and Kvantify announce new InnovateUK project, CoaxChem, to develop novel quantum solution to batteries

Microbiotica Ltd

Microbiotica reveals novel mechanisms showing how the microbiome can improve immunotherapy response based on MB097, a clinical-stage drug candidate being evaluated in combination with KEYTRUDA® (pembrolizumab) in patients with advanced melanoma

Artios Pharma

Artios Pharma Reports Differentiated Clinical Activity in STELLA Phase 1/2a Study for Lead Program ART0380 at the American Association for Cancer Research (AACR) Annual Meeting 2025

Iksuda Therapeutics Ltd

Iksuda to present growing ADC pipeline at AACR

Oxford Nanopore Technologies Plc

Oxford Nanopore expands Compatible Products Programme and strengthens multi-omics ecosystem

Oxford Nanopore Technologies Plc

Oxford Nanopore and Cepheid partner to advance automated sequencing-based solutions

First Light Fusion Ltd

Frazer-Nash Consultancy and First Light Fusion research to advance fusion energy

Akamis Bio

Akamis Bio Announces Enrollment of First Patient in Phase 1b FORTRESS Trial of NG-350A in Patients with Locally Advanced Rectal Cancer

Oxford Quantum Circuits Limited

OQC appoints new Chairman of Board

Bramble Energy Ltd

New £1.5m UK-Taiwan initiative targets next-gen hydrogen production with Bramble Energy’s breakthrough electrolyser technology